Molecular Biology of Bone Metastasis
Top Cited Papers
- 1 October 2007
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 6 (10) , 2609-2617
- https://doi.org/10.1158/1535-7163.mct-07-0234
Abstract
Metastasis is a final stage of tumor progression. Breast and prostate cancer cells preferentially metastasize to bone, wherein they cause incurable osteolytic and osteoblastic lesions. The bone matrix is rich in factors, such as transforming growth factor-β and insulin-like growth factors, which are released into the tumor microenvironment by osteolysis. These factors stimulate the growth of tumor cells and alter their phenotype, thus promoting a vicious cycle of metastasis and bone pathology. Physical factors within the bone microenvironment, including low oxygen levels, acidic pH, and high extracellular calcium concentrations, may also enhance tumor growth. These elements of the microenvironment are potential targets for chemotherapeutic intervention to halt tumor growth and suppress bone metastasis. [Mol Cancer Ther 2007;6(10):2609–17]Keywords
This publication has 91 references indexed in Scilit:
- Advances in Male ContraceptionEndocrine Reviews, 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell lineCancer Science, 2006
- Hypoxia-inducible factor-1α correlates with MET and metastasis in node-negative breast cancerBreast Cancer Research and Treatment, 2006
- Cross-talk between Epidermal Growth Factor Receptor and Hypoxia-inducible Factor-1α Signal Pathways Increases Resistance to Apoptosis by Up-regulating Survivin Gene ExpressionJournal of Biological Chemistry, 2006
- Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-β Type I Receptor Kinase InhibitorCancer Research, 2006
- Expression of the calcium receptor in human breast cancer—a potential new marker predicting the risk of bone metastasesEuropean Journal of Surgical Oncology, 2006
- Crosstalk between cancer cells and bone microenvironment in bone metastasisBiochemical and Biophysical Research Communications, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002